Circular Genomics, Inc., the world-leading developer of circular RNA-based precision medicine tools for neurology and psychiatry, today announced the successful closure of a $15 million Series A ...
Data from Master Clinical Trials—focused on transforming care for patients with acute myeloid leukemia—will be presented at ...
Quinlan Who Has Resigned for Health Reasons After Taking Medical Leave in September 2025 PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire / December 1, 2025 / Medicus Pharma Ltd. (NASDAQ:MDCX) ("Medicus" ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback